Dr. Ronald Leo Paquette, MD

Dr. Paquette practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Paquette's NPI, 1992725576, was assigned on July 19, 2006. Dr. Paquette graduated from Ohio State College of Medicine in 1984. Dr. Paquette holds California license G59889.

Dr. Paquette's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Paquette's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Paquette is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Paquette to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paquette practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Paquette's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Paquette is board certified in internal medicine by the American Board of Internal Medicine. Dr. Paquette is licensed in California.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), immune deficiency disease, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Paquette treats.

CMS data shows 797 Medicare services from Dr. Paquette across 8 procedure codes in 2024, for 206 Medicare patients. Medicare paid $58,827 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 206 Medicare patients who saw Dr. Paquette in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Paquette's median patient age at 68, with 42% women.

In 2024, Dr. Paquette wrote 640 Medicare Part D claims for 92 patients. 61% of them were for generic drugs. CMS names the drug for 406 of them, across 19 drugs with 11 or more claims each, at $2,690,615 in total drug cost. In 2023, CMS named 406 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Paquette for performance year 2024, reported as part of a group. Dr. Paquette accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Paquette as offering telehealth.

Dmand AI links 24 papers to Dr. Paquette, published from 2002 to 2021. 2012 was the busiest year, with 4. Dr. Paquette's most frequent co-authors are Roger M. Lyons, MD, Elliott F. Winton, MD and Murat Osman Arcasoy, MD.

Dmand AI links Dr. Paquette to 8 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Anemia, Aplastic, Bone Marrow Failure Disorders and Anemia, Sickle Cell. Cedars-Sinai Medical Center sponsors the most, 2.

CMS Open Payments shows 89 general payments to Dr. Paquette from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 65% of the total. Novartis Pharmaceuticals Corporation paid the most, $12,494. It also lists 1 research payment totaling $410 in 2019.

Dmand AI lists 1 award for Dr. Paquette.

Dr. Paquette graduated from Ohio State College of Medicine in 1984.

Dr. Paquette is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.